申请人:Buck Institute for Research on Aging
公开号:US10202355B2
公开(公告)日:2019-02-12
In certain embodiments hydantoin compounds are provided herein that are effective to inhibit BACE activity against APP. Without being bound to a particular theory, it is believed the activity of the hydantoins identified herein appears to be associated with binding to BACE and/or to APP particularly when these moieties form a BACE/APP complex. Accordingly, it is believed the compounds described herein represent a new class of compounds designated herein as APP-Binding-BACE Inhibitors (ABBIs) and provide a new mechanism to modulate APP processing. The hydantoins described herein appear to show improved brain permeability and functional BACE inhibition.
在某些实施方案中,本文提供的海因化合物可有效抑制 BACE 对 APP 的活性。在不拘泥于特定理论的前提下,我们认为本文所确定的海因的活性似乎与 BACE 和/或 APP 的结合有关,特别是当这些分子形成 BACE/APP 复合物时。因此,我们认为本文所述的化合物代表了一类新的化合物,本文将其命名为 APP 结合-BACE 抑制剂 (ABBI),并提供了一种调节 APP 处理过程的新机制。本文所述的 hydantoins 似乎具有更好的脑渗透性和功能性 BACE 抑制作用。